#Base_Editing
Breakthrough tBE Gene Editing Therapy Offers Hope for Sickle Cell and β-Thalassemia Patients Worldwide#Shanghai#USA#gene_therapy#CorrectSequence#Base_Editing
Breakthrough tBE Gene Editing Therapy Offers Hope for Sickle Cell and β-Thalassemia Patients Worldwide
A recent study reveals that tBE-mediated base editing therapy achieves consistent success in treating sickle cell disease and β-thalassemia across genetic backgrounds, showing promise for patients worldwide.
third-news.com
September 8, 2026 at 12:13 AM
Transformative Base Editing Therapy Shows Long-lasting Effectiveness for Sickle Cell Disease#Shanghai#USA#Sickle_Cell#CorrectSequence#Base_Editing
Transformative Base Editing Therapy Shows Long-lasting Effectiveness for Sickle Cell Disease
CorrectSequence Therapeutics has announced the successful results of their innovative base editing therapy for sickle cell disease, yielding long-term freedom from crisis.
third-news.com
June 3, 2026 at 2:36 PM
Innovative Base-Editing Therapy Shows Promise in Sickle Cell Disease Treatment with Long-Term Efficacy#Shanghai#USA#sickle_cell_disease#CorrectSequence#Base_Editing
Innovative Base-Editing Therapy Shows Promise in Sickle Cell Disease Treatment with Long-Term Efficacy
CorrectSequence Therapeutics has reported positive outcomes from its innovative base-editing therapy for sickle cell disease, showing sustained efficacy and safety over 15 months.
third-news.com
June 2, 2026 at 5:02 AM
In addition to uncovering CYB5R4 our functional map hints at many additional regulatory pathways and mechanisms that can now be explored by the community. Thanks to Norman Davey this will be facilitated through a website allowing exploration of the base editor screens slim.icr.ac.uk/base_editing...
SLiM team resources @ ICR
slim.icr.ac.uk
February 16, 2025 at 1:45 PM